These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
959 related items for PubMed ID: 26402083
41. Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's disease. Handels RL, Xu W, Rizzuto D, Caracciolo B, Wang R, Winblad B, Verhey FR, Severens JL, Fratiglioni L, Joore MA, Wimo A. J Alzheimers Dis; 2013; 37(2):357-65. PubMed ID: 23948894 [Abstract] [Full Text] [Related]
42. High specificity of MMSE pentagon scoring for diagnosis of prodromal dementia with Lewy bodies. Cagnin A, Bussè C, Jelcic N, Gnoato F, Mitolo M, Caffarra P. Parkinsonism Relat Disord; 2015 Mar; 21(3):303-5. PubMed ID: 25547859 [Abstract] [Full Text] [Related]
43. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up. Conde-Sala JL, Garre-Olmo J, Vilalta-Franch J, Llinàs-Reglà J, Turró-Garriga O, Lozano-Gallego M, Hernández-Ferrándiz M, Pericot-Nierga I, López-Pousa S. Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151 [Abstract] [Full Text] [Related]
44. Is Mild Cognitive Impairment a Precursor of Alzheimer's Disease? Short Review. Janoutová J, Šerý O, Hosák L, Janout V. Cent Eur J Public Health; 2015 Dec; 23(4):365-7. PubMed ID: 26841152 [Abstract] [Full Text] [Related]
45. Self-reported and informant-reported memory functioning and awareness in patients with mild cognitive impairment and Alzheimer´s disease. Silva MR, Moser D, Pflüger M, Pusswald G, Stögmann E, Dal-Bianco P, Auff E, Lehrner J. Neuropsychiatr; 2016 Jun; 30(2):103-12. PubMed ID: 27294268 [Abstract] [Full Text] [Related]
46. Depressive symptoms influence global cognitive impairment indirectly by reducing memory and executive function in patients with mild cognitive impairment. Yatawara C, Lim L, Chander R, Zhou J, Kandiah N. J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1375-1383. PubMed ID: 28103200 [Abstract] [Full Text] [Related]
47. Redefining Amnestic Mild Cognitive Impairment as an Early Form of Alzheimer's Disease Based on Assessment of Memory Systems. Bolívar JC, Saladie DG. J Alzheimers Dis; 2016 May 04; 53(2):705-12. PubMed ID: 27163821 [Abstract] [Full Text] [Related]
48. Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study. Pocnet C, Antonietti JP, Donati A, Popp J, Rossier J, von Gunten A. Int Psychogeriatr; 2015 Aug 04; 27(8):1379-89. PubMed ID: 25592615 [Abstract] [Full Text] [Related]
49. Recognition Memory Performance as a Cognitive Marker of Prodromal Alzheimer's Disease. Goldstein FC, Loring DW, Thomas T, Saleh S, Hajjar I. J Alzheimers Dis; 2019 Aug 04; 72(2):507-514. PubMed ID: 31594225 [Abstract] [Full Text] [Related]
50. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia. Davis M, O Connell T, Johnson S, Cline S, Merikle E, Martenyi F, Simpson K. Curr Alzheimer Res; 2018 Aug 04; 15(8):777-788. PubMed ID: 29357799 [Abstract] [Full Text] [Related]
51. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. Vos SJ, Verhey F, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Morbelli S, Frisoni GB, Drzezga A, Didic M, van Berckel BN, Simmons A, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Muscio C, Herukka SK, Salmon E, Bastin C, Wallin A, Nordlund A, de Mendonça A, Silva D, Santana I, Lemos R, Engelborghs S, Van der Mussele S, Alzheimer’s Disease Neuroimaging Initiative, Freund-Levi Y, Wallin ÅK, Hampel H, van der Flier W, Scheltens P, Visser PJ. Brain; 2015 May 04; 138(Pt 5):1327-38. PubMed ID: 25693589 [Abstract] [Full Text] [Related]
52. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample. Egli SC, Hirni DI, Taylor KI, Berres M, Regeniter A, Gass A, Monsch AU, Sollberger M. J Alzheimers Dis; 2015 May 04; 44(2):625-33. PubMed ID: 25322924 [Abstract] [Full Text] [Related]
53. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study. Tahmasebi R, Zehetmayer S, Pusswald G, Kovacs G, Stögmann E, Lehrner J. Int Psychogeriatr; 2019 Apr 04; 31(4):537-549. PubMed ID: 30236169 [Abstract] [Full Text] [Related]
54. Differences between episodic and semantic memory in predicting observation-based activities of daily living in mild cognitive impairment and Alzheimer's disease. Nakhla MZ, Banuelos D, Pagán C, Gavarrete Olvera A, Razani J. Appl Neuropsychol Adult; 2022 Apr 04; 29(6):1499-1510. PubMed ID: 33689539 [Abstract] [Full Text] [Related]
55. Serial position effects are sensitive predictors of conversion from MCI to Alzheimer's disease dementia. Egli SC, Beck IR, Berres M, Foldi NS, Monsch AU, Sollberger M. Alzheimers Dement; 2014 Oct 04; 10(5 Suppl):S420-4. PubMed ID: 24418056 [Abstract] [Full Text] [Related]
56. Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression. van de Beek M, van Steenoven I, van der Zande JJ, Barkhof F, Teunissen CE, van der Flier WM, Lemstra AW. Mov Disord; 2020 May 04; 35(5):859-867. PubMed ID: 32048343 [Abstract] [Full Text] [Related]
57. Semantic Memory as an Early Cognitive Marker of Alzheimer's Disease: Role of Category and Phonological Verbal Fluency Tasks. Marra C, Piccininni C, Masone Iacobucci G, Caprara A, Gainotti G, Costantini EM, Callea A, Venneri A, Quaranta D. J Alzheimers Dis; 2021 May 04; 81(2):619-627. PubMed ID: 33814440 [Abstract] [Full Text] [Related]
58. An Examination of Semantic Impairment in Amnestic MCI and AD: What Can We Learn From Verbal Fluency? Chasles MJ, Tremblay A, Escudier F, Lajeunesse A, Benoit S, Langlois R, Joubert S, Rouleau I. Arch Clin Neuropsychol; 2019 Jan 24; 35(1):22-30. PubMed ID: 30994886 [Abstract] [Full Text] [Related]
59. A Meta-Analysis of fMRI Activation Differences during Episodic Memory in Alzheimer's Disease and Mild Cognitive Impairment. Terry DP, Sabatinelli D, Puente AN, Lazar NA, Miller LS. J Neuroimaging; 2015 Jan 24; 25(6):849-60. PubMed ID: 26076800 [Abstract] [Full Text] [Related]
60. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters. Lindemer ER, Salat DH, Smith EE, Nguyen K, Fischl B, Greve DN, Alzheimer's Disease Neuroimaging Initiative. Neurobiol Aging; 2015 Sep 24; 36(9):2447-57. PubMed ID: 26095760 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]